Publications

EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer (in collaboration with ESC) Anna Falanga, Avi Leader, Chiara Ambaglio, Zsuzsa Bagoly, Giancarlo Castaman, Ismail Elalamy, Ramon Lecumberri, Alexander Niessner, Ingrid Pabinger, Sebastian Szmit, Alice Trinchero, Hugo Ten Cate, Bianca Rocca. HemaSphere, 2022 July 13;6(8): e750. Digital object identifier (DOI): 10.1097/HS9.0000000000000750

Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance Roger E.G. Schutgens, Victor Jimenez-Yuste, Miguel Escobar, Anna Falanga, Bruna Gigante, Robert Klamroth, Riitta Lassila, Frank W.G. Leebeek, Michael Makris, Tarek Owaidah, Michelle Sholzberg, Andreas Tiede, David J. Werring, H. Bart van der Worp, Jerzy Windyga, Giancarlo Castaman Hemasphere. 2023 June 5;7(6): e900. Digital object identifier (DOI): 10.1097/HS9.0000000000000900.

A consensus paper on “Management of antithrombotic therapy in patients with active cancer at high risk of bleeding” is ongoing in collaboration with the Council of Cardio-Oncology/Study Group on Thrombosis of the European Society of Cardiology (ESC), Anna Falanga is participating as a representative of SWG Bleeding and Thrombosis of EHA.

Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance
Schutgens REG, Jimenez-Yuste V, Escobar M, Falanga A, Gigante B, Klamroth R, Lassila R, Leebeek FWG, Makris M, Owaidah T, Sholzberg M, Tiede A, Werring DJ, van der Worp HB, Windyga J, Castaman G.
Hemasphere. 2023 Jun 5;7(6):e900.
Digital object identifier (DOI): 10.1097/HS9.0000000000000900.